Paula Deen reveals weight loss strategies in new cookbook
Celebrity chef Paula Deen says she and her family have lost a total of 178 pounds since she went on national TV last year and announced she was diagnosed two years prior with type 2 diabetes. The news...
View ArticleAAP issues first-ever guidelines for type 2 diabetes in children, teens
The American Academy of Pediatrics (AAP) has issued the first guidelines for the management of type 2 diabetes in children and teenagers aged 10 to 18. The guidelines were developed to assist...
View ArticleNewly approved type 2 diabetes drugs come with warnings, requirements
After more than five years of reviews and rejections, the dipeptidyl peptidase IV (DDP-4) inhibitor alogliptin has finally been approved by the Food and Drug Administration (FDA). The new drug was...
View ArticleBinge drinking may increase risk for type 2 diabetes
Knocking back way too many festive beverages causes insulin resistance, which can lead to type 2 diabetes, tests on lab rats reveals. The research is the first that links binge drinking alone – apart...
View ArticleBeer ingredient could be used to treat diabetes, cancer, inflammation
For the most part, alcohol use is discouraged for people with diabetes. But new research shows that an ingredient in beer can be incorporated into new drugs that could be used to treat conditions such...
View ArticleCanker sore, asthma drug to be tested as a treatment for obesity, diabetes
A drug used to treat canker sores may one day help patients who are obese or have diabetes, a new study suggests. The drug, amlexanox, was found to increase the basal metabolism of laboratory rats and...
View ArticleFDA requires more data on cardiovascular risks with Novo Nordisk’s new...
Novo Nordisk must complete a clinical trial on the cardiovascular effects of its long-acting insulin degludec drugs and correct deficiencies at its primary manufacturing plant before the Food and Drug...
View ArticleKentucky files Avandia lawsuit against GlaxoSmithKline
Drug maker GlaxoSmithKline (GSK) was slapped with a lawsuit by Kentucky’s attorney general, alleging that the company’s type 2 diabetes drug Avandia violated the state’s Consumer Protection Act by...
View ArticleFDA to review new type 2 diabetes treatment
The Food and Drug Administration (FDA) has started a review of Sanofi’s new once-daily type 2 diabetes drug lixisenatide. The drug was approved last month by European Union regulators, and will be...
View ArticleDiabetes medication may help obese children lose weight
A type 2 diabetes medication for adults may also help morbidly obese youths lose weight, a new study by researchers at the University of Minnesota Medical School suggests. Childhood obesity is a...
View ArticleGSK applies for US, European approval of new type 2 diabetes drug Albiglutide
Months after GlaxoSmithKline (GSK) applied for U.S. approval to market its once-weekly type 2 diabetes drug Albiglutide, the pharmaceutical company has applied to European regulators. GSK is hoping...
View ArticleCost of diabetes rising as number of diabetics increases
The cost of diabetes rose more than 40 percent during the past five years, however the per-patient cost has remained roughly flat, according to new research that will be published in the April issue of...
View ArticlePaula Deen fesses up about her diabetes diagnosis, partnership to promote...
Food Network star Paula Deen says she was heartbroken when, in 2009, she was diagnosed with type 2 diabetes. “I loved my life and wondered, is my whole life gong to have to change? I had umpteen...
View ArticleDiet sodas linked to increased risk for type 2 diabetes
Diet sodas and drinks with fewer calories may seem like healthier choices over their sugary counterparts, but a new study shows diet drinks may actually be worse. New research has found that diet...
View ArticleFDA investigates cases of pancreatitis, precancerous pancreatic cancer with...
An increased risk of pancreatitis, or inflammation of the pancreas, and other precancerous cellular changes called pancreatic duct metaplasia in patients with type 2 diabetes treated with a class of...
View ArticleNovo Nordisk testing higher doses of Victoza as weight loss drug for obese...
Novo Nordisk is hoping data from a phase III trial involving a higher dosage of its type 2 diabetes drug Victoza (liraglutide) will show it can help overweight and obese people with the chronic disease...
View ArticleEuropean drug regulators investigate pancreas risks with popular type 2...
The European Medicines Agency is investigating whether a class of type 2 diabetes medications increases the risk of pancreatitis (inflammation of the pancreas) and precancerous cellular changes called...
View ArticleFDA approves new type 2 diabetes drug, orders studies on cancer, organ risks
A new type 2 diabetes drug that works differently than all others currently on the market has been approved by the Food and Drug Administration (FDA). Invokana, made by Johnson & Johnson, is a...
View ArticleStudy finds Actos is no better than diabetes drugs from other class and may...
Type 2 diabetes drugs in a class known as glitazones, such as Actos and Avandia, carry significant adverse side effects and are not preferable to diabetes drugs of other classes, new research...
View ArticleLow melatonin levels may increase risk for type 2 diabetes
More evidence has surfaced suggesting low levels of melatonin, the naturally occurring hormone in humans that regulates sleep-wake cycles, increases the risk for type 2 diabetes. The new study, which...
View Article
More Pages to Explore .....